Intelligyn envisions a future where every woman receiving a gynecological imaging exam obtains accurate diagnostics right from the beginning.

IntelligynAI uses patent pending state-of-the-art deep-learning technology, based on pioneering research, to improve ovarian cancer diagnostics.

While scanning, selected ultrasound images of ovarian tumours are sent for AI analysis, and within seconds, the ovarian cancer risk prediction is sent back to the examiner.

Our AI models have a diagnostic accuracy beyond both non-expert and expert ultrasound examiners, with a stable performance across populations, ultrasound systems, and tumour subtypes.

*IntelligynAI capabilities are not yet approved for sale and distribution and should not be used outside of an approved clinical trial setting.